Related Experiment Video
Updated: Aug 15, 2026

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
Helicobacter pylori infection in children: prevalence, diagnosis and treatment outcome
Manisha Singh1, Kashi N Prasad, Surender K Yachha
1Department of Microbiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226 014, India.
Insights
Helicobacter pylori infection is common in children with upper abdominal pain, increasing with age. Eradicating H. pylori (Helicobacter pylori) effectively resolves symptoms in most children.
Area of Science:
- Pediatric Gastroenterology
- Infectious Diseases
- Microbiology
Background:
- The clinical significance and prevalence of Helicobacter pylori (H. pylori) infection in children are not well-established.
- Age-specific acquisition rates and reliable diagnostic methods for H. pylori in pediatric gastroduodenal disease require further investigation.
Purpose of the Study:
- To prospectively determine the prevalence of H. pylori infection in children.
- To assess the association between H. pylori infection and gastroduodenal disease, specifically upper abdominal pain (UAP).
Main Methods:
- Evaluated 240 children undergoing upper gastrointestinal endoscopy.
- Utilized rapid urease test, culture, ureA PCR, and histopathology for H. pylori detection.
- Compared H. pylori prevalence in children with UAP (n=58) versus controls (n=182).
Main Results:
- H. pylori infection was significantly higher in children with UAP (53.4%) compared to controls (28%) (P<0.001).
- Overall H. pylori prevalence increased with age.
- Eradication therapy was successful in 82% after the first regimen and 100% after a second regimen, with sustained symptom relief.
Conclusions:
- H. pylori infection is strongly linked to upper abdominal pain in children and its prevalence increases with age.
- Successful eradication of H. pylori leads to long-term symptom resolution in pediatric patients.
- Chronic inflammation is a consistent finding in H. pylori-infected children.
Abstract:
The clinical significance of Helicobacter pylori infection in children remains largely unknown. The rate of acquisition at different ages has not been ascertained using reliable tests on gastric biopsies. We determined prospectively the prevalence of H. pylori infection in children and its association with gastroduodenal disease. We evaluated 240 children undergoing upper gastrointestinal endoscopy for H. pylori infection by rapid urease test, culture, ureA PCR and histopathology. Group I constituted 58 children with upper abdominal pain (UAP) and group II (controls) of 182 children without UAP who underwent diagnostic or therapeutic endoscopy for other reasons. Helicobacter pylori-positive children with UAP received anti-H. pylori therapy. Helicobacter pylori infection was significantly higher in children with UAP than controls (53.4% vs. 28%; P<0.001) and overall prevalence increased with age. On follow-up endoscopy, H. pylori had been eradicated from 82% of children with UAP; it was eradicated from the remaining 18% after a second regimen. Treated H. pylori-positive children with UAP remained symptom-free for a median of 25 months. Control children remained chronically H. pylori infected. Chronic inflammation was present in all infected children, and active inflammation in 48.8%. The study shows H. pylori infection increases with age and is strongly linked to UAP in children.
More Related Videos
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
06:40Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
Published on: July 28, 2023
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Gastritis II: Pathophysiology
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease II: Pathophysiology